kr524.00
1.26%
Stockholm, Sep 30, 05:29 pm CEST. Closed.
ISIN
SE0009160872
Symbol
MCAP

MedCap AB Stock price

kr524.00
-36.50 6.51% 1M
+58.00 12.45% 6M
-25.00 4.55% YTD
-41.00 7.26% 1Y
+251.50 92.29% 3Y
+332.60 173.77% 5Y
+485.50 1,261.04% 10Y
+510.00 3,642.86% 20Y
Stockholm, Closing price Wed, Sep 30 2026
+6.50 1.26%

AI Insights on MedCap AB Insights AI Insights on MedCap AB

What are the key opportunities and risks?
How is the company managed?

Is MedCap AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
kr7.9b
Enterprise Value
kr8.1b
Net debt
kr171.3m
Cash
kr286.3m
Shares outstanding
15.0m
Valuation (TTM | estimate)
P/E
32.6
P/S
3.5 | 3.3
EV/Sales
3.6 | 3.4
EV/FCF
25.2
P/B
5.0
Financial Health
Equity Ratio
55.7%
Return on Equity
15.1%
ROCE
15.5%
ROIC
13.1%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
kr2.3b | kr2.4b
EBITDA
kr521.8m
EBIT
kr345.4m
Net Income
kr240.7m
Free Cash Flow
kr320.7m
Growth (TTM | estimate)
Revenue
18.5% | 15.1%
EBITDA
33.5%
EBIT
30.4%
Net Income
21.2%
Free Cash Flow
20.0%
Margin
Gross
59.4%
EBITDA
23.1%
EBIT
15.3%
Net
10.7%
Free Cash Flow
14.2%
More
EPS
kr16.1
FCF per Share
kr21.4
Short interest
-
Employees
637
Rev per Employee
kr3.3m

MedCap AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a MedCap AB forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a MedCap AB forecast:

Buy
86%
Hold
14%

Financial data from MedCap AB

Jun '26
+/-
%
2,255 2,255
19% 19%
100%
- Direct Costs 917 917
8% 8%
41%
1,339 1,339
27% 27%
59%
- Selling and Administrative Expenses 579 579
17% 17%
26%
- Research and Development Expense - -
-
-
522 522
33% 33%
23%
- Depreciation and Amortization 176 176
40% 40%
8%
EBIT (Operating Income) EBIT 345 345
30% 30%
15%
Net Profit 241 241
21% 21%
11%

In millions SEK.

Don't miss a Thing! We will send you all news about MedCap AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Stockholm, Stockholm and currently employs 583 full-time employees. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

Head office Sweden
CEO Mr. Dahlberg
Employees 637
Website www.medcap.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today